{
    "startDate": "2019-04-01",
    "endDate": "2020-03-31",
    "year": "2020",
    "quarter": "FY",
    "symbol": "UROV",
    "data": {
        "bs": [
            {
                "label": "Cash",
                "concept": "Cash",
                "unit": "usd",
                "value": 51414000
            },
            {
                "label": "Restricted cash",
                "concept": "RestrictedCashCurrent",
                "unit": "usd",
                "value": 243000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 6489000
            },
            {
                "label": "Due from Sumitovant Biopharma Ltd.",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 172000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 58318000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 1210000
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 3135000
            },
            {
                "label": "Restricted cash, net of current portion",
                "concept": "RestrictedCashNoncurrent",
                "unit": "usd",
                "value": 623000
            },
            {
                "label": "Other assets",
                "concept": "AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 9000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 63295000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 1589000
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 21756000
            },
            {
                "label": "Due to Roivant Sciences Ltd.",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 31000
            },
            {
                "label": "Current portion of share-based compensation liabilities",
                "concept": "DeferredCompensationShareBasedArrangementsLiabilityCurrent",
                "unit": "usd",
                "value": 7204000
            },
            {
                "label": "Current portion of operating lease liabilities",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 351000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 30931000
            },
            {
                "label": "Share-based compensation liabilities, net of current portion",
                "concept": "DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent",
                "unit": "usd",
                "value": 32000
            },
            {
                "label": "Related-party long-term debt",
                "concept": "DueToRelatedPartiesNoncurrent",
                "unit": "usd",
                "value": 87252000
            },
            {
                "label": "Operating lease liabilities, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 3086000
            },
            {
                "label": "Liabilities and Shareholders' (Deficit) Equity",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 121301000
            },
            {
                "label": "Commitments and contingencies (Note 11)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common shares, par value $0.000037453 per share, 267,001,308 shares authorized, 30,635,258 and 30,322,911 issued and outstanding at March 31, 2020 and 2019, respectively",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Common shares subscribed",
                "concept": "CommonStockShareSubscribedButUnissuedSubscriptionsReceivable",
                "unit": "usd",
                "value": 1000
            },
            {
                "label": "Accumulated other comprehensive income",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 452000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 263818000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -322276000
            },
            {
                "label": "Shareholders' (deficit) equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -58006000
            },
            {
                "label": "Liabilities and Shareholders' (Deficit) Equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 63295000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -146745000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 246000
            },
            {
                "label": "Share-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 20483000
            },
            {
                "label": "Amortization of debt discount and issuance costs",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 675000
            },
            {
                "label": "Non-cash operating lease cost.",
                "concept": "urov:NoncashOperatingLeaseCost",
                "unit": "usd",
                "value": 640000
            },
            {
                "label": "Loss on extinguishment of long-term debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": -4093000
            },
            {
                "label": "Loss on disposal of property and equipment",
                "concept": "GainLossOnSaleOfPropertyPlantEquipment",
                "unit": "usd",
                "value": -236000
            },
            {
                "label": "Unrealized foreign currency translation adjustment",
                "concept": "ForeignCurrencyTransactionGainLossUnrealized",
                "unit": "usd",
                "value": -183000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -6590000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherCurrentAssets",
                "unit": "usd",
                "value": -79000
            },
            {
                "label": "Due from Sumitovant Biopharma Ltd.",
                "concept": "IncreaseDecreaseInDueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 172000
            },
            {
                "label": "Increase (decrease) in due to related party current.",
                "concept": "urov:IncreaseDecreaseInDueToRelatedPartyCurrent",
                "unit": "usd",
                "value": 16000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -336000
            },
            {
                "label": "Accrued expenses",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 12266000
            },
            {
                "label": "Increase (decrease) in operating lease liabilities.",
                "concept": "urov:IncreaseDecreaseInOperatingLeaseLiabilities",
                "unit": "usd",
                "value": -338000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -102084000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquireFurnitureAndFixtures",
                "unit": "usd",
                "value": 769000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -769000
            },
            {
                "label": "Proceeds from capital contributions from Roivant Sciences Ltd.",
                "concept": "ProceedsFromContributedCapital",
                "unit": "usd",
                "value": 251000
            },
            {
                "label": "Proceeds from exercise of stock options",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 796000
            },
            {
                "label": "Payment of stock options and restricted stock units tax withholding on net settlement",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 946000
            },
            {
                "label": "Debt financing costs paid",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 645000
            },
            {
                "label": "Repayment of long-term debt and redemption fees",
                "concept": "RepaymentsOfLongTermDebtAndCapitalSecurities",
                "unit": "usd",
                "value": 47854000
            },
            {
                "label": "Cash proceeds from third-party debt financing",
                "concept": "ProceedsFromDebtNetOfIssuanceCosts",
                "unit": "usd",
                "value": 30000000
            },
            {
                "label": "Cash proceeds from related-party debt financing",
                "concept": "ProceedsFromRelatedPartyDebt",
                "unit": "usd",
                "value": 87500000
            },
            {
                "label": "Deferred offering costs paid",
                "concept": "PaymentsOfStockIssuanceCosts",
                "unit": "usd",
                "value": 165000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 68937000
            },
            {
                "label": "Net change in cash and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -33916000
            },
            {
                "label": "Warrants issued with long-term debt.",
                "concept": "urov:WarrantsIssuedWithLongTermDebt",
                "unit": "usd",
                "value": 438000
            },
            {
                "label": "Reclassification of share-based compensation expense from additional paid-in capital to liabilities",
                "concept": "urov:ReclassificationOfShareBasedCompensationExpenseFromAdditionalPaidInCapitalToLiabilities",
                "unit": "usd",
                "value": 4074000
            },
            {
                "label": "Income taxes",
                "concept": "IncomeTaxesPaidNet",
                "unit": "usd",
                "value": 65000
            },
            {
                "label": "Interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 3081000
            }
        ],
        "ic": [
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 92437000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 46299000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 138736000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestIncomeExpenseNet",
                "unit": "usd",
                "value": -3581000
            },
            {
                "label": "Loss on extinguishment of long-term debt",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": -4093000
            },
            {
                "label": "Loss on disposal of property and equipment",
                "concept": "GainLossOnSaleOfPropertyPlantEquipment",
                "unit": "usd",
                "value": -236000
            },
            {
                "label": "Other expense:",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -34000
            },
            {
                "label": "Loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
                "unit": "usd",
                "value": -146680000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 65000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -146745000
            },
            {
                "label": "Net loss per common share\u2014basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -4.82
            },
            {
                "label": "Weighted average common shares outstanding\u2014basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 30416641
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 183000
            },
            {
                "label": "Other comprehensive income:",
                "concept": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
                "unit": "usd",
                "value": 183000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -146562000
            }
        ]
    }
}